癌症结局的差异：从癌症患儿身上吸取的教训。
Disparities in cancer outcomes: lessons learned from children with cancer.
机构信息
Department of Population Sciences, City of Hope, Duarte, CA 91010, USA.
出版信息
Pediatr Blood Cancer. 2011 Jun;56(6):994-1002. doi: 10.1002/pbc.23078. Epub 2011 Feb 15.
Abstract
Disparities in cancer burden by race/ethnicity have been reported, primarily in adults with cancer. However, there appear to be gaps in the pediatric oncology literature with regards to a comprehensive overview on this topic. Extant literature is used to highlight the results of studies focusing on racial and ethnic disparities in outcome observed in selected childhood cancers. A comprehensive approach is utilized to understand possible underlying causes of disparities in cancer outcomes, and to highlight the gaps that currently exist. This review helps define areas of future research that could help develop targeted, disease-specific approaches to eliminate the disparities.
摘要
种族/民族的癌症负担差异已被报道，主要见于成人癌症患者。然而，儿科肿瘤学文献在这一主题的全面概述方面似乎存在差距。现有文献用于突出显示研究结果，这些研究重点关注在某些儿童癌症中观察到的种族和民族间结局差异。采用综合方法来了解癌症结局差异的潜在原因，并突出当前存在的差距。本综述有助于确定未来研究的领域，这些研究有助于制定有针对性的、针对特定疾病的方法来消除差异。
相似文献
1
Disparities in cancer outcomes: lessons learned from children with cancer.
Pediatr Blood Cancer. 2011 Jun;56(6):994-1002. doi: 10.1002/pbc.23078. Epub 2011 Feb 15.
2
Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
Cancer. 2016 Sep 1;122(17):2723-30. doi: 10.1002/cncr.30089. Epub 2016 Jun 10.
3
Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
JAMA. 2003 Oct 15;290(15):2008-14. doi: 10.1001/jama.290.15.2008.
4
Race/ethnicity and the risk of childhood leukaemia: a case-control study in California.
J Epidemiol Community Health. 2015 Aug;69(8):795-802. doi: 10.1136/jech-2014-204975. Epub 2015 Mar 19.
5
A Literature Review of Racial Disparities in Overall Survival of Black Children With Acute Lymphoblastic Leukemia Compared With White Children With Acute Lymphoblastic Leukemia.
J Pediatr Oncol Nurs. 2020 May/Jun;37(3):180-194. doi: 10.1177/1043454220907547. Epub 2020 Feb 24.
6
Cancer statistics by race and ethnicity.
CA Cancer J Clin. 1998 Jan-Feb;48(1):31-48. doi: 10.3322/canjclin.48.1.31.
7
Population-Based Analysis of Demographic and Socioeconomic Disparities in Pediatric CNS Cancer Survival in the United States.
Sci Rep. 2020 Mar 12;10(1):4588. doi: 10.1038/s41598-020-61237-2.
8
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
Lancet Haematol. 2023 Feb;10(2):e129-e141. doi: 10.1016/S2352-3026(22)00371-4.
9
Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
JAMA Netw Open. 2020 Apr 1;3(4):e202950. doi: 10.1001/jamanetworkopen.2020.2950.
10
Geographic Variations of Racial/Ethnic Disparities in Late-Stage Diagnosis of Childhood Cancer in Texas.
South Med J. 2020 May;113(5):224-231. doi: 10.14423/SMJ.0000000000001097.
引用本文的文献
1
Contemporary Characteristics and Outcomes of Pediatric Oncology Patients Participating in Early Phase Clinical Trials.
Cancer Med. 2025 Sep;14(17):e71222. doi: 10.1002/cam4.71222.
2
Beyond Barriers: Achieving True Equity in Cancer Care.
Curr Oncol. 2025 Jun 12;32(6):349. doi: 10.3390/curroncol32060349.
3
The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children's Oncology Group.
HGG Adv. 2025 Jul 10;6(3):100466. doi: 10.1016/j.xhgg.2025.100466. Epub 2025 Jun 9.
4
Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult Patients.
Cancers (Basel). 2025 Apr 30;17(9):1519. doi: 10.3390/cancers17091519.
5
Co-Designing Priority Components of an mHealth Intervention to Enhance Follow-Up Care in Young Adult Survivors of Childhood Cancer and Health Care Providers: Qualitative Descriptive Study.
JMIR Cancer. 2025 Apr 25;11:e57834. doi: 10.2196/57834.
6
Disparities in Clinical Trial Participation in Children and Adolescent Patients With a Hematologic Malignancy.
Pediatr Blood Cancer. 2025 Jun;72(6):e31641. doi: 10.1002/pbc.31641. Epub 2025 Mar 7.
7
Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group Report.
JAMA Netw Open. 2025 Feb 3;8(2):e2458531. doi: 10.1001/jamanetworkopen.2024.58531.
8
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.
Transplant Cell Ther. 2025 Apr;31(4):224.e1-224.e13. doi: 10.1016/j.jtct.2024.12.019. Epub 2024 Dec 27.
9
Racism in Pediatric Serious Illness and Palliative Care: A Scoping Review of Qualitative Research.
J Pain Symptom Manage. 2025 Jan;69(1):44-52. doi: 10.1016/j.jpainsymman.2024.09.021. Epub 2024 Oct 1.
10
Sociodemographic and Socioeconomic Factors Correlate with Late-Stage Pediatric Hodgkin Lymphoma and Rhabdomyosarcoma: A Report from the Children's Oncology Group Registries.
Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1327-1338. doi: 10.1158/1055-9965.EPI-24-0510.
本文引用的文献
1
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.
J Clin Oncol. 2011 Jan 1;29(1):76-82. doi: 10.1200/JCO.2010.29.6103. Epub 2010 Nov 22.
2
Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?
J Gen Intern Med. 2009 Nov;24 Suppl 2(Suppl 2):S395-400. doi: 10.1007/s11606-009-0995-8.
3
Racial/ethnic diversity in children's oncology clinical trials: ten years later.
Cancer. 2009 Aug 15;115(16):3808-16. doi: 10.1002/cncr.24437.
4
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
J Clin Oncol. 2009 Mar 1;27(7):1007-13. doi: 10.1200/JCO.2007.13.8925. Epub 2009 Jan 26.
5
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
J Clin Oncol. 2009 Mar 1;27(7):1034-40. doi: 10.1200/JCO.2008.17.5877. Epub 2009 Jan 26.
6
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.
7
Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999.
Cancer. 2008 Nov 1;113(9):2575-96. doi: 10.1002/cncr.23866.
8
Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma.
J Clin Oncol. 2008 Mar 10;26(8):1282-8. doi: 10.1200/JCO.2007.14.0699.
9
Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study.
Pharmacogenomics. 2008 Mar;9(3):303-9. doi: 10.2217/14622416.9.3.303.
10
Diagnosis delays in childhood cancer: a review.
Cancer. 2007 Aug 15;110(4):703-13. doi: 10.1002/cncr.22849.
Zotero 插件